You are here

  • Home
  • Archive
  • Volume 104, Issue 6
  • Dupilumab-induced ocular surface disease (DIOSD) in patients with atopic dermatitis: clinical presentation, risk factors for development and outcomes of treatment with tacrolimus ointment

Citation Tools

Article menu
Download PDFPDF
Clinical science
Dupilumab-induced ocular surface disease (DIOSD) in patients with atopic dermatitis: clinical presentation, risk factors for development and outcomes of treatment with tacrolimus ointment

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Nahum Y, Mimouni M, Livny E, et al
Dupilumab-induced ocular surface disease (DIOSD) in patients with atopic dermatitis: clinical presentation, risk factors for development and outcomes of treatment with tacrolimus ointment
British Journal of Ophthalmology 2020;104:776-779.